A Reversal in the Vascularity of Metastatic Liver Tumors in Patients With Colorectal Cancer After the Cessation of Anti-VEGF Therapy: A Study Using Contrast-enhanced Ultrasonography and Histological Techniques.
N/A
N/A
N/A
N/A
N/A
Not Enrolling
Both
Colorectal Cancer
Both
Colorectal Cancer
Trial Information
A Reversal in the Vascularity of Metastatic Liver Tumors in Patients With Colorectal Cancer After the Cessation of Anti-VEGF Therapy: A Study Using Contrast-enhanced Ultrasonography and Histological Techniques.
Inclusion Criteria:
- patients who received chemotherapy (FOLFOX) including bevacizumab. The patients had
an associated reduction in tumor vascularity as estimated by ultrasonography and
consequently underwent surgical resection of the metastatic liver tumors for curative
purposes.
Exclusion Criteria:
- none
Type of Study:
Observational
Study Design:
Time Perspective: Retrospective
Authority:
Japan: Institutional Review Board
Study ID:
24-1
NCT ID:
NCT01591109
Start Date:
January 2010
Completion Date:
April 2012
Related Keywords:
- Colorectal Cancer
- Colorectal Neoplasms
- Liver Neoplasms
Name | Location |
|---|
